Softwr

Healthcare · head to head

Koa Health vs Therapixel

Koa Health logo

Koa Health

Healthcare

Employer and health plan digital mental health, acquired by PsychPlus in June 2026

From
On request
Rated
-
Full reviewWebsite
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Koa Health psychPlus acquired Koa Health in June 2026, so buyers are now contracting with the technology arm of an American psychiatry provider group rather than a European digital health company, and roadmap, data residency and European product investment should all be re-examined before renewal.; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • They diverge on capability: Koa Health covers Stepped care triage, Therapixel covers MammoScreen 2D.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Koa Health and Therapixel actually diverge.

Attributes where Koa Health and Therapixel differ
AttributeKoa HealthTherapixel
PlatformsWeb, iOS, AndroidWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Koa Health

  • Stepped care triage
  • Self guided digital modules
  • Coaching tier
  • Licensed clinical care
  • Employer and plan reporting
  • Multi country delivery
  • Clinical governance

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

Koa Health

  • An employer that wants something between a meditation app and a full clinical benefit, with triage deciding which members need a cliniciannot Therapixel
  • A European health plan needing a digital mental health offering with clinical governance and local language deliverynot Therapixel
  • A health system wanting to absorb low acuity behavioural health demand before it reaches scarce psychiatry appointmentsnot Therapixel
  • A multinational standardising a stepped care pathway across several European markets under one contractnot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot Koa Health
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot Koa Health
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot Koa Health
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot Koa Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Koa Health

  • PsychPlus acquired Koa Health in June 2026, so buyers are now contracting with the technology arm of an American psychiatry provider group rather than a European digital health company, and roadmap, data residency and European product investment should all be re-examined before renewal.
  • Stepped care only produces savings when triage is accurate, and members routed to a self guided module when they believe they need a therapist commonly disengage entirely, which a utilisation report records as low engagement rather than as a triage failure.
  • Pricing is per employee or per member per month across the eligible population, so an employer with modest engagement pays for everyone in order to serve a minority.
  • Clinician availability and language coverage differ substantially by country, so a multinational contract that reads as one global standard delivers a materially different experience in secondary markets.
  • Koa competes against much larger and better funded benefits vendors in the United States, and the acquisition does not change the fact that its brand recognition with American benefits consultants is low, which affects broker driven shortlists.

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

Koa Health

On request
  • Koa Health$undefined/year
    • Per employee per month or per member per month, quoted not published
    • Rate depends on which steps of the care ladder are included
    • Clinical tier access priced separately from digital content access

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose Koa Health if

  • You need stepped care triage.
  • You work on Web, iOS, Android.
  • You also want self guided digital modules.
Koa Health review

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.
Therapixel review

Questions people ask

Is Koa Health or Therapixel better?
Neither clearly leads. Koa Health starts at On request and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Koa Health or Therapixel?
Koa Health starts at On request and Therapixel at On request.
Does Koa Health or Therapixel run on more platforms?
Koa Health runs on Web, iOS, Android. Therapixel runs on Web.
What is Koa Health best used for?
Koa Health is most often used for an employer that wants something between a meditation app and a full clinical benefit, with triage deciding which members need a clinician, a european health plan needing a digital mental health offering with clinical governance and local language delivery, a health system wanting to absorb low acuity behavioural health demand before it reaches scarce psychiatry appointments, a multinational standardising a stepped care pathway across several european markets under one contract. Of those, an employer that wants something between a meditation app and a full clinical benefit, with triage deciding which members need a clinician and a european health plan needing a digital mental health offering with clinical governance and local language delivery are not what Therapixel is typically brought in for.
What can Koa Health do that Therapixel cannot?
Koa Health covers Stepped care triage, Self guided digital modules, Coaching tier, Licensed clinical care. Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

Koa Health: Is Koa Health still operating?

Yes. PsychPlus acquired it in June 2026 and the brand and platform continue. It is not a shutdown, but the ownership and clinical direction have changed.

Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Koa Health: Who buys Koa Health?

Employers, health plans and health systems. It is not sold direct to individuals.

Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Koa Health: How is it priced?

Per employee or per member per month, quoted rather than published, with the rate depending on which steps of the care ladder are in scope.

Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Koa Health: Does it provide access to psychiatrists?

Clinical access is included in the higher tiers, and the PsychPlus acquisition adds psychiatry provider capacity in the United States. Confirm what your specific contract covers.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

More on Koa Health

More on Therapixel

Keep looking

Other head to heads